Display options
Share it on

eNeuro. 2015 Mar 23;2(1). doi: 10.1523/ENEURO.0075-14.2015. eCollection 2015.

The Polg Mutator Phenotype Does Not Cause Dopaminergic Neurodegeneration in DJ-1-Deficient Mice.

eNeuro

David N Hauser, Christopher T Primiani, Rebekah G Langston, Ravindran Kumaran, Mark R Cookson

Affiliations

  1. Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health , Bethesda, Maryland 20892.

PMID: 26464968 PMCID: PMC4586922 DOI: 10.1523/ENEURO.0075-14.2015

Abstract

Mutations in the DJ-1 gene cause autosomal recessive parkinsonism in humans. Several mouse models of DJ-1 deficiency have been developed, but they do not have dopaminergic neuron cell death in the substantia nigra pars compacta (SNpc). Mitochondrial DNA (mtDNA) damage occurs frequently in the aged human SNpc but not in the mouse SNpc. We hypothesized that the reason DJ-1-deficient mice do not have dopaminergic cell death is due to an absence of mtDNA damage. We tested this hypothesis by crossing DJ-1-deficient mice with mice that have similar amounts of mtDNA damage in their SNpc as aged humans (Polg mutator mice). At 1 year of age, we counted the amount of SNpc dopaminergic neurons in the mouse brains using both colorimetric and fluorescent staining followed by unbiased stereology. No evidence of dopaminergic cell death was observed in DJ-1-deficient mice with the Polg mutator mutation. Furthermore, we did not observe any difference in dopaminergic terminal immunostaining in the striatum of these mice. Finally, we did not observe any changes in the amount of GFAP-positive astrocytes in the SNpc of these mice, indicative of a lack of astrogliosis. Altogether, our findings demonstrate the DJ-1-deficient mice, Polg mutator mice, and DJ-1-deficient Polg mutator mice have intact nigrastriatal pathways. Thus, the lack of mtDNA damage in the mouse SNpc does not underlie the absence of dopaminergic cell death in DJ-1-deficient mice.

Keywords: DJ-1; Polg mutator; mtDNA; neurodegeration; parkinsonism; substantia nigra

References

  1. Genes Brain Behav. 2010 Apr;9(3):305-17 - PubMed
  2. Curr Opin Neurobiol. 2013 Feb;23 (1):100-8 - PubMed
  3. J Neurosci Methods. 1997 Apr 25;73(1):45-8 - PubMed
  4. Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11441-6 - PubMed
  5. Science. 2003 Jan 10;299(5604):256-9 - PubMed
  6. Mitochondrion. 2013 Jul;13(4):282-91 - PubMed
  7. Brain. 2004 Feb;127(Pt 2):420-30 - PubMed
  8. Neuron. 2005 Feb 17;45(4):489-96 - PubMed
  9. Science. 2005 Jul 15;309(5733):481-4 - PubMed
  10. Nature. 1998 Apr 9;392(6676):605-8 - PubMed
  11. Brain Res. 1982 Mar 4;235(1):93-103 - PubMed
  12. Hum Mol Genet. 2003 Sep 15;12 (18):2277-91 - PubMed
  13. Neurobiol Dis. 2013 Mar;51:35-42 - PubMed
  14. Neurobiol Dis. 2014 Feb;62:113-23 - PubMed
  15. Brain. 2013 Aug;136(Pt 8):2369-78 - PubMed
  16. Science. 2004 May 21;304(5674):1158-60 - PubMed
  17. J Neurochem. 2009 Nov;111(3):696-702 - PubMed
  18. Nat Genet. 2006 May;38(5):518-20 - PubMed
  19. Neurobiol Dis. 2008 Mar;29(3):505-14 - PubMed
  20. PLoS One. 2014 Apr 10;9(4):e94646 - PubMed
  21. PLoS One. 2013 Dec 26;8(12 ):e84894 - PubMed
  22. Nat Genet. 2006 May;38(5):515-7 - PubMed
  23. Antioxid Redox Signal. 2011 Jul 1;15(1):111-22 - PubMed
  24. J Biol Chem. 2003 Oct 31;278(44):43628-35 - PubMed
  25. Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15918-23 - PubMed
  26. J Biol Chem. 2005 Jun 3;280(22):21418-26 - PubMed
  27. Neurobiol Dis. 2007 Aug;27(2):141-50 - PubMed
  28. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14 ):5215-20 - PubMed
  29. Res Commun Chem Pathol Pharmacol. 1985 Dec;50(3):435-41 - PubMed
  30. J Neurochem. 2011 May;117(3):375-87 - PubMed

Publication Types